[1]
Sadowski K., Jóźwiak S.: Recent advances in pathophysiology studies
and treatment of epilepsy in neurocutaneous disorders. J Epileptol 2014;
22: 89–98.
[2]
Annapurna S., Simone L. A-H.: Sturge-Weber syndrome: From past to
the present. Eur J Paediatr Neurol 2004; 18: 257–266.
[3]
Nabbout R., Juhasz C.: Sturge-Weber syndrome. [w:] Handbook of
Clinical neurology. Vol. III (3rd series) Pediatric neurology. Part I. Dulac
O., Lassonde M., Sarnat HB. [ed.], Elsevier B.V., Amsterdam 2013.
[4]
Shirley M. D., Tang H., Gallione C., et al.: A GNAQ somatic mutation
causes Sturge-Weber syndrome and port-wine stains. N Engl J Med
2013; 368: 1971–1979.
[5]
Lo W., Marchuk D. A., Ball K. L., et al.: Updates and future horizones on
the understanding, diagnosis and treatment of Sturge-Weber syndrome
brain involvement. Dev Med Child Neurol 2012; 54(3): 214–223.
[6]
Alkonyi B., Chugani H. T., Karia S., et al.: Clinical outcomes In bilateral
Sturge-Weber syndrome. Pediatr Neurol 2011; 44: 443–449.
[7]
Pascual-Castroviejo I., Pascual-Pascual S. I., Velazquez-Fragua R., et al.:
Sturge-Weber syndrome: study of 55 patients. Can J Neurol Sci 2008;
35: 301–307.
[8]
Comi A. M.: Pathophysiology of Sturge-Weber Syndrome. J Child Neurol
2003; 18: 509.
[9]
Baheti N. N., Krishnan S., Thomas B., et al.: Stroke-like episodes in
Sturge-Weber syndrome. Neurol India 2010; 58: 797–799.
[10]
Jansen F. E., van der Worp H. B., van Huffelen A., et al.: Sturge-Weber
syndrome and paroxysmal hemiparesis: epilepsy or ischaemia? Dev
Med Child Neurol 2004; 46(11): 783–786.
[11]
Kossoff E. H., Hatfield L. A., Ball K. L., et al.: Comorbidity of epilepsy
and headache in patients with Sturge-Weber syndrome. J Child Neurol
2005; 20: 678–682.
[12]
Iizuka T., Sakai F., Yamakawa K., et al.: Vasogenic leakage and the
mechanism of migraine with prolonged aura in Sturge-Weber syndrome.
Cephalalgia 2004; 24: 767–770.
[13]
Freilinger T., Peters N., Remi J., et al.: A case of Sturge-Weber syndrome
with symptomatic hemiplegic migraine: clinical and multimodality
imaging data during a prolonged attack. J Neurol Sci 2009; 287: 271–
274.
[14]
Sujansky E., Conradi S.: Outcome of Sturge-Weber syndrome in 52
adults. Am J Med Genet 1995; 57: 35–45.
[15]
Griffiths P. D., Boodram M. B., Blaser S., et al.: Abnormal ocular
enhancement in Sturge-Weber syndrome: correlation of ocular MR and
CT findings with clinical and intracranial imaging findings. AJNR Am J
Neuroradiol 1996; 17(4): 749–754.
[16]
Susac J. O., Smith J. L., Scelfo R. J.: The “tomato-catsup” fundus in
Sturge-Weber syndrome. Arch Ophthal 1974; 92: 69–70.
[17]
Comi A. M., Bellamkonda S., Ferenc L. M., et al.: Central hypothyroidism
and Sturge-Weber syndrome. Pediatr Neurol 2008; 39: 58–62.
[18]
Łątkowski I. T., Wysocki M. S., Siewiera I. P.: Własne doświadczenia w
leczeniu pacjentów z malformacjami naczyniowymi typu port-wine stain
przy użyciu lasera KTP 532 NM. Wiad Lek 2005; 58: 391–396.
[19]
Chapas A. M., Eickhorst K., Geronemus R. G.: Efficacy of early treatment
of facial port wine stains in newborns: a review of 49 cases. Lasers Surg
Med 2007; 39: 563–568.
[20]
Frieden I. J., Haggstrom A. N., Drolet B. A., et al.: Infantile hemangiomas:
current knowledge, future directions: proceedings of a research
workshop on infantile hemangiomas, April 7-9, 2005, Bethesda,
Maryland, USA. Pediatr Dermatol 2005; 22: 383–406.
[21]
Léauté-Labrèze C., Dumas de la Roque E., Hubiche T., et al.: Propranolol
for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649–
2651.
[22]
Madreperla S. A., Hungerford J. L., Plowman P. N., et al.: Choroidal
hemangiomas: visual and anatomic results of treatment by
photocoagulation or radiation therapy. Ophthalmology 1997; 104: 1773–
1779.
[23]
Thapa R., Shields C. L.: Oral propranolol therapy for management of
exudative retinal detachment from diffuse choroidal hemangioma in
Sturge-Weber syndrome. Eur J Ophthalmol 2013; 23 (6): 917–919.
[24]
Iwach A. G., Hoskins H. D. Jr, Hetherington J. Jr, et al.: Analysis of
surgical and medical management of glaucoma in Sturge-Weber
syndrome. Ophthalmology 1990; 97: 904–909.
[25]
Sharan S., Swamy B., Taranath D. A., et al.: Port-wine vascular
malformations and glaucoma risk in Sturge-Weber syndrome. J AAPOS
2009; 13(4): 374–378.
[26]
Patrianakos T. D., Nagao K., Walton D. S.: Surgical management of
glaucoma with the Sturge Weber syndrome. Int Ophthalmol Clin 2008;
48: 63–78.
[27]
Comi A. M.: Sturge-Weber syndrome and epilepsy: an argument for
aggressive seizure management in these patients. Expert Rev Neurother
2007; 7: 951–956.
[28]
Kossoff E.H., Balasta M., Hatfield L. M., et al.: Self-reported treatment
patterns in patients with Sturge-Weber syndrome and migraines. J Child
Neurol. 2007; 22: 720–726.
[29]
Maria B. L., Neufeld J. A., Rosainz L. C., et al.: Central nervous system
structure and function in Sturge-Weber syndrome: evidence of neurologic
and radiologic progression. J Child Neurol 1998; 13: 606–618.
[30]
Bay M. J., Kossoff E. H., Lehmann C. U., et al.: Survey of aspirin use in
Sturge-Weber syndrome. J Child Neurol 2011; 26: 692–702.
[31]
Ville D., Enjolras O., Chiron C., et al.: Prophylactic antiepileptic treatment
in Sturge-Weber disease. Seizure 2002; 11(3): 145–150.
[32]
Jóźwiak S., Kotulska K., Domanska-Pakiela D., et al.: Antiepileptic
treatment before the onset of seizures reduces epilepsy severity and
risk of mental retardation in infants with tuberous sclerosis complex. Eur
J Paediatr Neurol 2011; 15: 424–431.
[33]
Pinto A., Sahin M., Pearl P. L.: Epileptogenesis in neurocutaneous
disorders with focus in Sturge-Weber syndrome. F1000Research 2016;
5: 370.
[34]
Lance E. I., Sreenivasan A. K., Zabel T. A., Kossoff E. H., Comi A. M.,
et al.: Aspirin use in Sturge-Weber syndrome: side effects and clinical
outcomes. J Child Neurol 2013; 28(2): 213–218.
[35]
Namer I. J., Battaglia F., Hirsch E., et al.: Subtraction ictal SPECT
coregistered to MRI (SISCOM) in Sturge-Weber syndrome. Clin Nucl
Med 2005; 30: 39–40.
[36]
Arzimanoglou A. A., Andermann F., Aicardi J., et al.: Sturge-Weber
syndrome: indications and results of surgery in 20 patients. Neurology
2000; 55: 1472–1479.
[37]
Kossoff E. H., Borsage J. L., Comi A. M.: A pilot study of the modified
Atkins diet for Sturge-Weber syndrome. Epilepsy Res 2010; 92: 240–
243.
Scholar Google
PubMed